Abhraka Bhasma (mica based nanomedicine): an ayurvedic herbomineral perspective in breast cancer management

The traditional Ayurvedic rationale for <i>Abhraka Bhasma</i> correlates with reported preclinical mechanisms. Thus, the ancient wisdom and modern evidence make <i>Abhraka Bhasma</i> an important part of integrative oncology, which offers a complementary strategy to improve patient outcomes. Available evidence on <i>Abhraka Bhasma</i> in cancer treatment is currently preclinical data (Level 5) and hypothesis generating only. To date, no RCTs or cohort studies (Levels 1-3) on the safety and efficacy of <i>Abhraka Bhasma</i> as an adjunct in breast cancer treatment have been published. To bridge the gap between traditional use and evidence based clinical application, a structured and systematic research pathway is essential.